C12N 2760/18661
Methods of inactivation or attenuation
C12N2760/18661 (Methods of inactivation or attenuation) appears on 23 US grants and 28 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 28
- Assignees
- 20
- Inventors
- 34
- Latest grant
- 5 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 3 | 3 |
| 2005 | 1 | 2 |
| 2006 | 0 | 2 |
| 2007 | 4 | 1 |
| 2008 | 1 | 4 |
| 2009 | 2 | 1 |
| 2010 | 2 | 3 |
| 2011 | 3 | 3 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 0 |
By publication year.
Subgroups
Granted patents
Recent patents
- Method for production of reprogrammed cell using chromosomally unintegrated virus vector5 Oct 2021US 11,136,594 B2ID Pharma Co., Ltd.
- Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom25 May 2021US 11,013,796 B2Iowa State University Research Foundation, Inc.
- Method for production of reprogrammed cell using chromosomally unintegrated virus vector4 Jul 2017US 9,695,445 B2ID Pharma Co., Ltd.
- Paramyxovirus immunogens and related materials and methods21 Feb 2017US 9,572,876 B2Ohio State Innovation Foundation
- Method for production of reprogrammed cell using chromosomally unintegrated virus vector8 Sep 2015US 9,127,256 B2DNAVEC Corporation
- Novel porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom5 Mar 2020US 2020/0069789 A1Iowa State University Research Foundation, Inc.
- Paramyxovirus Immunogens and Related Materials and Methods23 Mar 2017US 2017/0080081 A1Ohio State Innovation Foundation
- Method for production of reprogrammed cell using chromosomally unintegrated virus vector23 Jun 2016US 2016/0177337 A1ID Pharma Co., Ltd.
- Method for production of reprogrammed cell using chromosomally unintegrated virus vector26 Nov 2015US 2015/0337334 A1DNAVEC Corporation
- Paramyxovirus Immunogens and Related Materials and Methods19 Mar 2015US 2015/0079117 A1Ohio State Innovation Foundation
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- DNA transfection system for the generation of infectious influenza virus45US 7,312,064 B2St. Jude Children's Research Hosptal · 2007
- DNA-transfection system for the generation of infectious influenza virus41US 7,972,843 B2St. Jude Children?S Research Hospital · 2011
- DNA transfection system for the generation of negative strand RNA virus30US 8,309,099 B2St. Jude Children?S Research Hospital · 2012
- Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences28US 7,208,161 B1The United States of America, as represented by the Secretary, Department of Health and Human Services · 2007